VARIAD DIAGNOSTICS
VariAD developed a unique patent-pending test to detect pre-disposition for Crohn’s Disease. The test, code named – deNoVA, analyzes the genetic makeup of the patient and determines the likelihood of the patient to develop Crohn’s as well as the severity level of the pre-disposition. Since this is a genetic test, samples are extracted from the patient through a simple, non-invasive procedure. Evaluated by an independent panel using clinical data, the deNoVa tool demonstrated high-accuracy, correctly identifying 96% of Crohn's patients based on their genome data alone.
VARIAD DIAGNOSTICS
Industry:
Biotechnology Genetics Health Care Medical
Founded:
2014-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.variaddx.com
Total Employee:
1+
Status:
Closed
Total Funding:
100 K USD
Similar Organizations
CapNostics
Detection of Barrett’s Esophagus
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
Current Employees Featured
Founder
